Results
1
-
1
of
1
Phase I trial of antigen-targeted autologous dendritic cell-based vaccine with in vivo activation of inducible CD40 for advanced prostate cancer
,
Cancer Immunology, Immunotherapy
[DOI: 10.1007/s00262-017-2027-6]